| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242045 | Respiratory Medicine | 2014 | 11 Pages |
Abstract
In Canadian patients with inadequately controlled asthma on FP, it is cost-effective to use SFC for patients 12 years and over compared to doubling their FP dose. It is also cost-effective to use SFC for patients on low or medium dose FP compared to remaining on the current FP dose in patients with uncontrolled asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Afisi S. Ismaila, Nancy Risebrough, Chunmei Li, Diane Corriveau, Neil Hawkins, J. Mark FitzGerald, Zhen Su,